Surgical Outcomes of Patients with Gastrointestinal Stromal Tumors in the Era of Targeted Drug Therapy
- 11 June 2008
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 12 (11) , 2023-2031
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Surgically Managed Gastrointestinal Stromal Tumors: A Comparative and Prognostic AnalysisAnnals of Surgical Oncology, 2007
- Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)British Journal of Cancer, 2007
- Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma GroupJournal of Clinical Oncology, 2007
- Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutantsGastroenterology, 2005
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal TumorsArchives of Surgery, 2001
- Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective DatabaseAnnals of Surgical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Gastric stromal tumors Reappraisal of histogenesisAmerican Journal of Surgical Pathology, 1983